Table 3.
Utilization of medications stratified by clinical endpoints.
| Drugs | Discharged (n = 399) | Deceased (n = 45) |
Chi-square p-value |
|---|---|---|---|
| Repurposed drugs | |||
| Ivermectin | 70 (17.5) | 3 (6.7) | 0.062 |
| Remdesivir | 184 (46.1) | 16 (35.6) | 0.177 |
| Azithromycin | 125 (31.3) | 3 (6.7) | 0.001 |
| Corticosteroids | |||
| Dexamethasone | 363 (91.0) | 42 (93.3) | 0.583 |
| Hydrocortisone | 10 (2.5) | 7 (15.6) | 0.001 |
| Budesonide Inhaler | 100 (25.1) | 35 (77.8) | 0.001 |
| Methylprednisolone | 4 (1.0) | 4 (8.9) | 0.001 |
| At least one corticosteroid | 373 (93.5) | 43 (95.6) | 0.999 |
| Repurposed drugs + corticosteroids | 269 (67.4) | 18 (40.0) | 0.005 |
| Antimicrobials | |||
| Ceftriaxone | 161 (40.4) | 7 (15.6) | 0.001 |
| Moxifloxacin | 167 (41.9) | 36 (80.0) | 0.001 |
| Piperacillin-Tazobactam | 63 (15.8) | 3 (6.7) | 0.103 |
| Meropenem | 45 (11.3) | 5 (11.1) | 0.973 |
| At least one antimicrobial | 335 (84.0) | 42 (93.3) | 0.123 |
| Antithrombotic | |||
| Enoxaparin | 18 (4.5) | 8 (17.8) | 0.003 |
| Rivaroxaban | 160 (40.1) | 34 (75.6) | 0.001 |
| Aspirin | 62 (15.5) | 4 (8.9) | 0.235 |
| At least one antithrombotic | 227 (56.9) | 40 (88.9) | 0.050 |
| Miscellaneous | |||
| Statin | 8 (2.0) | 1 (2.2) | 0.923 |
| Cetirizine | 10 (2.5) | 5 (11.1) | 0.012 |
| Montelukast | 175 (43.9) | 35 (77.8) | 0.001 |
| Omeprazole | 310 (77.7) | 38 (84.4) | 0.280 |